Skip to main content

Table 4 Univariate analysis of the risk factors for transfusion in THA

From: The incidence and risk factors for allogenic blood transfusion in total knee and hip arthroplasty

Variable

Non-transfusion (n = 824)

Transfusion (n = 169)

P value

Female gender (%)

491 (59.6)

132 (78.1)

< 0.001*

Age, years (mean ± SD)

63.7 (14.1)

61.9 (15.2)

0.142

BMI, kg/m2 (mean ± SD)

23.4 (3.7)

23.6 (3.9)

0.518

Diabetes (%)

78 (9.5)

17 (10.1)

0.811

Hypertension (%)

250 (30.3)

59 (34.9)

0.242

Malignance (%)

22 (2.7)

3 (1.8)

0.499

Smoking (%)

107 (13.0)

21 (12.4)

0.843

Diagnosis

  

0.019*

 OA (%)

119 (14.4)

33 (19.5)

 

 RA (%)

8 (1.0)

6 (3.6)

 

 Femoral neck fracture (%)

346 (42.0)

55 (32.5)

 

 ONFH (%)

216 (26.2)

39 (23.1)

 

 DDH (%)

83 (10.1)

23 (13.6)

 

 AS (%)

44 (5.3)

10 (5.9)

 

 Previous septic arthritis (%)

8 (1.0)

3 (1.8)

 

PT, s (mean ± SD)

11.6 (1.0)

11.7 (1.1)

0.177

INR (mean ± SD)

1.02 (0.09)

1.03 (0.11)

0.146

APTT, s (mean ± SD)

27.4 (4.9)

27.5 (4.1)

0.698

Preoperative Hb level, g/L (mean ± SD)

130.1 (15.1)

119.1 (14.4)

< 0.001*

PLT, 109/L (mean ± SD)

197.8 (62.5)

193.0 (63.0)

0.361

Operation time, min (mean ± SD)

99.6 (28.0)

117.9 (36.4)

< 0.001*

Intraoperative blood loss, mL (mean ± SD)

314.6 (163.5)

456.0 (183.3)

< 0.001*

  1. SD standard deviation, BMI body mass index, OA osteoarthritis, RA rheumatoid arthritis, ONFH osteonecrosis of the femur head, DDH developmental dysplasia of the hip, AS ankylosing spondylitis, PT prothrombin time, INR international normalized ratio, APTT activated partial thromboplastin time, Hb hemoglobin, PLT platelet count
  2. *P < 0.05 was considered statistically significant